Products
Online Inquiry
Go6976
Cat. No.:
OB0225WX-2667
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Go6976 is a potent PKC inhibitor specifically targeting the alpha and beta-1 isoforms (IC50: 2.3 nM and 6.2 nM) and serves as an effective antagonist of JAK2 and Flt3.
Synonym:
PD406976; 136194-77-9; Go 6976; GO6976; Go-6976; Goe 6976; 3-(13-Methyl-5-oxo-6,7-dihydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-12(13H)-yl)propanenitrile; 12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole; 12H-Indolo(2,3-a)pyrrolo(3,4-c)carbazole-12-propanenitrile, 5,6,7,13-tetrahydro-13-methyl-5-oxo-; 12H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-12-propanenitrile, 5,6,7,13-tetrahydro-13-methyl-5-oxo-; 12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo[2,3-a]pyrolo[3,4-c]carbazole; 3-(13-methyl-5-oxo-5,6,7,13-tetrahydro-12H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-12-yl)propanenitrile; 5,6,7,13-Tetrahydro-13-Methyl-5-oxo-12H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-12-propanenitrile; Goe-6976; 3-(23-methyl-14-oxo-3,13,23-triazahexacyclo[14.7.0.0^{2,10.0^{4,9.0^{11,15.0^{17,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-3-yl)propanenitrile; 3-(23-methyl-14-oxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-3-yl)propanenitrile; 3-{23-methyl-14-oxo-3,13,23-triazahexacyclo[14.7.0.0(2),(1)?.0?,?.0(1)(1),(1)?.0(1)?,(2)(2)]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-3-yl}propanenitrile
CAS No.:
136194-77-9
Compound CID:
3501
Formula:
C24H18N4
Formula Weight:
377.42
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Go6976 is utilized in biochemical research as a potent inhibitor of conventional PKC isoforms and PKD to investigate the role of kinase-mediated signaling in cell cycle regulation and calcium-dependent processes.
Library Information
Target:
FLT3; JAK; PKC
Receptor:
FLT3; JAK; PKCα; PKCβ1
Pathways:
TGF-beta/Smad
Plate Number:
L6700-08
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
18 mg/mL; 47.69 mM
ALogP:
4.168
HBA_Count:
1
HBD_Count:
1
Rotatable Bond:
2





